US Stock Insider Trading | NeuroOne Medical disclosed two insider transactions on March 12

K-LinePoet · 2026-04-08T10:47:51+00:00

On March 12, 2026, NeuroOne Medical disclosed internal personnel trading activity, with executive Christianson Mark selling 11.6k shares on March 11. The company focuses on medical technology related to brain diseases.

K-LinePoet

2026-04-08 10:47:51

Abstract generation in progress

On March 12, 2026, NeuroOne Medical (NMTC) disclosed two instances of insider trading by company insiders. On March 11, 2026, executive Christianson Mark sold 11.6k shares.

[Recent Insider Trades]

Disclosure date	Position	Name	Trade date	Buy/Sell	Quantity	Price per share/US$	Total amount/US$
March 12, 2026	Executive	Christianson Mark	March 11, 2026	Sold	13.7k	0.80	11.0k
March 3, 2026	Executive	Wambeke David J.	March 1, 2026	Bought	670.4k	0.67	11.6k
February 20, 2026	Director	Rosa David A	February 18, 2026	Sold	71.3k	0.68	48.5k
February 20, 2026	Executive	Mertens Steve	February 18, 2026	Sold	7376	0.68	5015.68
February 20, 2026	Executive	Christianson Mark	February 18, 2026	Sold	1812	0.68	1232.16
January 5, 2026	Executive	Mertens Steve	December 31, 2025	Sold	906	0.76	686.75
January 5, 2026	Executive	Christianson Mark	December 31, 2025	Sold	253	0.76	191.77
January 5, 2026	Director	Rosa David A	December 31, 2025	Bought	2458	0.76	1863.16
October 1, 2025	Executive	Mertens Steve	September 30, 2025	Sold	906	0.89	805.07
October 1, 2025	Executive	Christianson Mark	September 30, 2025	Sold	253	0.89	224.82

[Company Profile]

NeuroOne Medical Technologies Corporation was incorporated on August 20, 2009, under the laws of the State of Delaware. The company is a medical technology company focused on diagnostic, ablation, and deep brain stimulation technologies for brain-related diseases such as epilepsy and Parkinson’s disease; ablation and stimulation for whole-body pain management; and drug delivery, including diagnostic and stimulation capabilities.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

2 Likes